← Back to headlines
Astellas Pharma and Siemens Energy Reaffirm Financial Outlooks
Astellas Pharma reported GAAP EPS of ¥78.96 and revenue of ¥640.91B, reaffirming its FY 2027 outlook. Siemens Energy AG also reaffirmed its FY2026 outlook after reporting GAAP EPS of €1.26 and revenue of €11.45B.
5 Aug, 06:38 — 5 Aug, 06:38
Sources
Showing 1 of 1 sources
Related Stories
Fed Chair Warsh Warns of Persistent Inflation, Signals Potential Rate Hikes at Jackson Hole
17m ago
UEFA Prepares Criminal Complaint Against FIFA President Gianni Infantino
30m ago
Walmart Reaches Settlement With US Government Over Opioid Lawsuit
45m ago
Major Corporations Announce Quarterly Cash Dividend Payouts
1h ago